| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $22K | -76.8% |
| R&D Expense | $192.3M | -20.8% |
| SG&A Expense | $65.2M | -9.0% |
| Operating Income | -$273.2M | +16.6% |
| Pre-tax Income | -$257.1M | +21.4% |
| Income Tax | $443K | — |
| Net Income | -$257.6M | +21.3% |
| EPS (Basic) | -$1.32 | +36.8% |
| EPS (Diluted) | -$1.32 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.2M | -9.5% |
| Current Assets | $303.4M | -33.9% |
| Total Assets | $548.7M | -14.6% |
| Current Liabilities | $35.5M | -4.2% |
| Total Liabilities | $126.5M | -3.1% |
| Stockholders' Equity | $422.2M | -17.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$200.3M | +15.7% |
| Capital Expenditures | $694K | -54.2% |
| Investing Cash Flow | $75.7M | -53.6% |
| Financing Cash Flow | $116.7M | +21.9% |
| Free Cash Flow | -$201.0M | +16.0% |
| +36.8% |